Probiotics in luminal gastroenterology: the current state of play

Simple item page
dc.contributor.authorAndrews, J.M.
dc.contributor.authorTan, M.
dc.date.issued2012
dc.description.abstractIn recent years, there has been a growing interest in the use of probiotics in various areas of gastrointestinal (GI) health. Probiotics are defined as live microorganisms that provide beneficial health effects on the host when administered in adequate amounts. Various probiotics have been shown to suppress bacterial growth, modulate the immune system and improve intestinal barrier function. However, despite several studies with promising results, most trials are small and many have substantial methodological limitations. However, with better targeting and appropriate randomised controlled trials, this area may soon yield important therapeutic strategies to optimise GI health. Here, we review the current knowledge of probiotics of relevance to luminal GI health.
dc.description.statementofresponsibilityJ. M. Andrews and M. Tan
dc.identifier.citationInternal Medicine Journal, 2012; 42(12):1287-1291
dc.identifier.doi10.1111/imj.12015
dc.identifier.issn1444-0903
dc.identifier.issn1445-5994
dc.identifier.orcidAndrews, J.M. [0000-0001-7960-2650]
dc.identifier.urihttp://hdl.handle.net/2440/90670
dc.language.isoen
dc.publisherWiley-Blackwell
dc.rights© 2012 The Authors
dc.source.urihttps://doi.org/10.1111/imj.12015
dc.subjectprobiotics; luminal gastroenterology; diarrhoea; inflammatory bowel disease; constipation
dc.titleProbiotics in luminal gastroenterology: the current state of play
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications